Evaluation of multiparametric magnetic resonance imaging in detection and prediction of prostate cancer

PLoS ONE

Volumn 10, Issue 6, 2015, Pages

  Wang, Rui ^a   Wang, He ^a   Zhao, Chenglin ^a   Hu, Juan ^b   Jiang, Yuanyuan ^a   Tong, Yanjun ^c   Liu, Ting ^d   Huang, Rong ^e   Wang, Xiaoying ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

^b KUNMING MEDICAL UNIVERSITY   (China)

^c AEROSPACE CENTRAL HOSPITAL   (China)

^d Dongzhimen Hospital of Beijing University of Chinese Medicine   (China)

^e PEKING UNIVERSITY SHENZHEN HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CANCER DIAGNOSIS; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; EVALUATION STUDY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PREDICTIVE VALUE; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE IMAGING REPORTING AND DATA SYSTEM; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; STANDARD; BIOLOGICAL MODEL; BLOOD; CLINICAL TRIAL; DIAGNOSTIC IMAGING; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PROSTATE TUMOR; RADIOGRAPHY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RADIOGRAPHY;

EID: 84935429823     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0130207     Document Type: Article

References (26)

1. Heijmink SW, Fütterer JJ, Strum SS, Oyen WJ, Frauscher F, Witjes JA, et al. State-of-the-art uroradiologic imaging in the diagnosis of prostate cancer. Acta Oncol. 2011; 50: 25-38. doi: 10.3109/0284186X.2010.578369 PMID: 21604938
2. Kirkham AP, Emberton M, Allen C. How good is MRI at detecting and characterising cancer within the prostate? Eur Urol. 2006; 50: 1163-75. PMID: 16842903
3. Heidenreich A, Bastian PJ, Bellmunt J, Bolla M, Joniau S, van der Kwast T, et al. EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013. Eur Urol. 2014; 65: 124-37. doi: 10.1016/j.eururo.2013.09.046 PMID: 24207135
4. Carter HB, Albertsen PC, Barry MJ, Etzioni R, Freedland SJ, Greene KL, et al. Early Detection of Prostate Cancer: AUA Guideline. J Urol. 2013; 190: 419-26. doi: 10.1016/j.juro.2013.04.119 PMID: 23659877
5. Hoeks CM, Barentsz JO, Hambrock T, Yakar D, Somford DM, Heijmink SW, et al. Prostate cancer: multiparametric MR imaging for detection, localization, and staging. Radiology. 2011; 261: 46-66. doi: 10.1148/radiol.11091822 PMID: 21931141
6. Portalez D, Rollin G, Leandri P, Elman B, Mouly P, Jonca F, et al. Prospective comparison of T2w-MRI and dynamic-contrast-enhanced MRI, 3D-MR spectroscopic imaging or diffusion-weighted MRI in repeat TRUS-guided biopsies. Eur Radiol. 2010; 20: 2781-90. doi: 10.1007/s00330-010-1868-6 PMID: 20680293
7. Villers A, Lemaitre L, Haffner J, Puech P. Current status of MRI for the diagnosis, staging and prognosis of prostate cancer: implications for focal therapy and active surveillance. Curr Opin Urol. 2009; 19: 274-82. doi: 10.1097/MOU.0b013e328329a2ed PMID: 19325494
8. Barentsz JO, Richenberg J, Clements R, Choyke P, Verma S, Villeirs G. ESUR prostate MR guidelines 2012. Eur Radiol. 2012; 22: 746-57. doi: 10.1007/s00330-011-2377-y PMID: 22322308
9. Dickinson L, Ahmed HU, Allen C, Barentsz JO, Carey B, Futterer JJ, et al. Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting. Eur Urol. 2011; 59: 477-94. doi: 10.1016/j.eururo.2010.12.009 PMID: 21195536
10. Heidenreich A. Consensus criteria for the use of magnetic resonance imaging in the diagnosis and staging of prostate cancer: not ready for routine use. Eur Urol. 2011; 59: 495-7. doi: 10.1016/j.eururo.2011.01.013 PMID: 21256671
11. Abd-Alazeez M, Kirkham A, Ahmed HU, Arya M, Anastasiadis E, Charman SC, et al. Performance of multiparametric MRI in men at risk of prostate cancer before the first biopsy: a paired validating cohort study using template prostate mapping biopsies as the reference standard. Prostate Cancer Prostatic Dis. 2014; 17: 40-6. doi: 10.1038/pcan.2013.43 PMID: 24126797
12. Schröder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V, et al. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med. 2009; 360(13): 1320-1328. doi: 10.1056/NEJMoa0810084 PMID: 19297566
13. Hugosson J, Carlsson S, Aus G, Bergdahl S, Khatami A, Lodding P, et al. Mortality results from the Göteborg randomised population-based prostate-cancer screening trial. Lancet Oncol. 2010; 11(8): 725-732. doi: 10.1016/S1470-2045(10)70146-7 PMID: 20598634
14. Tanimoto A, Nakashima J, Kohno H, Shinmoto H, Kuribayashi S. Prostate cancer screening: the clinical value of diffusion-weighted imaging and dynamic MR imaging in combination with T2-weighted imaging. J Magn Reson Imaging. 2007; 25: 146-52. PMID: 17139633
15. Komai Y, Numao N, Yoshida S, Matsuoka Y, Nakanishi Y, Ishii C, et al. High diagnostic ability of multiparametric magnetic resonance imaging to detect anterior prostate cancer missed by transrectal 12-core biopsy. J Urol. 2013; 190: 867-73. doi: 10.1016/j.juro.2013.03.078 PMID: 23542406
16. Thompson JE, Moses D, Shnier R, Brenner P, Delprado W, Ponsky L, et al. Multiparametric Magnetic resonance imaging guided diagnostic biopsy detects significant prostate cancer and could reduce unnecessary biopsies and over detection: a prospective study. J Urol. 2014; 192: 67-74. doi: 10.1016/j.juro.2014.01.014 PMID: 24518762
17. Junker D, Schafer G, Edlinger M, Kremser C, Bektic J, Horninger W, et al. Evaluation of the PI-RADS scoring system for classifying mpMRI findings in men with suspicion of prostate cancer. Biomed Res Int. 2013; 2013: 252939. doi: 10.1155/2013/252939 PMID: 24396825
18. Hamoen EH, de Rooij M, Witjes JA, Barentsz JO, Rovers MM. Use of the Prostate Imaging Reporting and Data System (PI-RADS) for Prostate Cancer Detection with Multiparametric Magnetic Resonance Imaging: A Diagnostic Meta-analysis. Eur Urol 2014 (in press).
19. Rosenkrantz AB, Kim S, Lim RP, Hindman N, Deng FM, Babb JS, et al. Prostate cancer localization using multiparametric MR imaging: comparison of Prostate Imaging Reporting and Data System (PI-RADS) and Likert scales. Radiology. 2013; 269: 482-92. doi: 10.1148/radiol.13122233 PMID: 23788719
20. Orsted DD, Nordestgaard BG, Jensen GB, Schnohr P, Bojesen SE. Prostate-specific antigen and long-term prediction of prostate cancer incidence and mortality in the general population. Eur Urol. 2012; 61: 865-74. doi: 10.1016/j.eururo.2011.11.007 PMID: 22104593
21. Lucarelli G, Fanelli M, Larocca AM, Germinario CA, Rutigliano M, Vavallo A, et al. Serum sarcosine increases the accuracy of prostate cancer detection in patients with total serum PSA less than 4.0 ng/ml. Prostate. 2012; 72: 1611-21. doi: 10.1002/pros.22514 PMID: 22430630
22. Miller K, Abrahamsson PA, Akakura K, Debruyne FMJ, Evans CP, Klotz L, et al. The continuing role of PSA in the detection and management of prostate cancer. Eur Urol Suppl. 2007; 6: 327-33.
23. Rais-Bahrami S, Siddiqui MM, Turkbey B, Stamatakis L, Logan J, Hoang AN, et al. Utility of multiparametric magnetic resonance imaging suspicion levels for detecting prostate cancer. J Urol. 2013; 190: 1721-7 doi: 10.1016/j.juro.2013.05.052 PMID: 23727310
24. Vargas HA, Akin O, Afaq A, Goldman D, Zheng J, Moskowitz CS, et al. Magnetic resonance imaging for predicting prostate biopsy findings in patients considered for active surveillance of clinically low risk prostate cancer. J Urol. 2012; 188: 1732. doi: 10.1016/j.juro.2012.07.024 PMID: 23017866
25. Fradet V, Kurhanewicz J, Cowan JE, Karl A, Coakley FV, Shinohara K, et al. Prostate cancer managed with active surveillance: role of anatomic MR imaging and MR spectroscopic imaging. Radiology. 2010; 256: 176-83. doi: 10.1148/radiol.10091147 PMID: 20505068
26. American College of Radiology. MR Prostate Imaging Reporting and Data System version 2.0. Accessed Month YYYY. Available: http://www.acr.org/Quality-Safety/Resources/PIRADS/.